Skip to Main content Skip to Navigation
Journal articles

High-density lipoproteins during sepsis: from bench to bedside

Abstract : High-density lipoproteins (HDLs) represent a family of particle characterized by the presence of apolipoprotein A-I (apoA-I) and by their ability to transport cholesterol from peripheral tissues back to the liver conferring them a cardioprotective function. HDLs also display pleiotropic properties including antioxidant, anti-apoptotic, antithrombotic, anti-inflammatory, or anti-infectious functions. Clinical data demonstrate that HDL cholesterol levels decrease rapidly during sepsis and that these low levels are correlated with morbi-mortality. Experimental studies emphasized notable structural and functional modifications of HDL particles in inflammatory states, including sepsis. Finally, HDL infusion in animal models of sepsis improved survival and provided a global endothelial protective effect. These clinical and experimental studies reinforce the potential of HDL therapy in human sepsis. In this review, we will detail the different effects of HDLs that may be relevant under inflammatory conditions and the lipoprotein changes during sepsis and we will discuss the potentiality of HDL therapy in sepsis.
Document type :
Journal articles
Complete list of metadata

https://hal.univ-reunion.fr/hal-03043637
Contributor : Réunion Univ <>
Submitted on : Monday, December 7, 2020 - 1:20:23 PM
Last modification on : Wednesday, June 30, 2021 - 9:40:15 PM

File

s13054-020-02860-3.pdf
Publisher files allowed on an open archive

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Citation

Sébastien Tanaka, David Couret, Alexy Tran-Dinh, Jacques Duranteau, Philippe Montravers, et al.. High-density lipoproteins during sepsis: from bench to bedside. Critical Care, BioMed Central, 2020, 24, pp.134. ⟨10.1186/s13054-020-02860-3⟩. ⟨hal-03043637⟩

Share

Metrics

Record views

127

Files downloads

206